tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ATHA Stock Latest News

Athira Pharma: Hold Rating Amid Strategic Uncertainty and Resource Challenges
RatingsAthira Pharma: Hold Rating Amid Strategic Uncertainty and Resource Challenges
28d ago
ATHA
Athira Pharma’s Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained
PremiumRatings
Athira Pharma’s Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained
1M ago
ATHA
Athira Pharma’s 2024 Financial Results and Pipeline Progress
PremiumCompany Announcements
Athira Pharma’s 2024 Financial Results and Pipeline Progress
1M ago
ATHA
Athira Pharma reports FY24 EPS ($2.52) vs. ($3.09) last year
PremiumThe Fly
Athira Pharma reports FY24 EPS ($2.52) vs. ($3.09) last year
1M ago
ATHA
Athira Pharma announces exploration of strategic alternatives
PremiumThe Fly
Athira Pharma announces exploration of strategic alternatives
1M ago
ATHA
Athira Pharma to pay $4M to settle False Claims Act allegations
PremiumThe FlyAthira Pharma to pay $4M to settle False Claims Act allegations
3M ago
ATHA
Athira Pharma’s Regulatory Compliance Challenges Threaten Drug Development Pipeline
Premium
Company Announcements
Athira Pharma’s Regulatory Compliance Challenges Threaten Drug Development Pipeline
5M ago
ATHA
Athira Pharma Reports Q3 2024 Financial Results
Premium
Company Announcements
Athira Pharma Reports Q3 2024 Financial Results
5M ago
ATHA
Athira Pharma reports Q3 EPS (75c), consensus (71c)
PremiumThe Fly
Athira Pharma reports Q3 EPS (75c), consensus (71c)
5M ago
ATHA
3 Penny Stocks to Watch Now, 11/5/24
PremiumMarket News
3 Penny Stocks to Watch Now, 11/5/24
5M ago
ATHA
TOVX
Athira Pharma to present results from Phase 2/3 LIFT-AD trial
PremiumThe Fly
Athira Pharma to present results from Phase 2/3 LIFT-AD trial
6M ago
ATHA
Athira Pharma files $300M mixed securities shelf
PremiumThe Fly
Athira Pharma files $300M mixed securities shelf
6M ago
ATHA
Athira Pharma downgraded to Neutral from Outperform at Mizuho
PremiumThe FlyAthira Pharma downgraded to Neutral from Outperform at Mizuho
7M ago
ATHA
Athira Pharma to focus on ATH-1105 advancement, reduces workforce by 70%
Premium
The Fly
Athira Pharma to focus on ATH-1105 advancement, reduces workforce by 70%
7M ago
ATHA
Goldman Sachs moves Athira Pharma to Not Rated
Premium
The Fly
Goldman Sachs moves Athira Pharma to Not Rated
7M ago
ATHA
Athira Pharma downgraded to Neutral from Buy at Rodman & Renshaw
PremiumThe Fly
Athira Pharma downgraded to Neutral from Buy at Rodman & Renshaw
7M ago
ATHA
Athira Pharma downgraded to Market Perform from Outperform at JMP Securities
PremiumThe Fly
Athira Pharma downgraded to Market Perform from Outperform at JMP Securities
7M ago
ATHA
Athira Pharma downgraded to Neutral from Buy at BTIG
PremiumThe Fly
Athira Pharma downgraded to Neutral from Buy at BTIG
7M ago
ATHA
Closing Bell Movers: GitLab up 14%, Zscaler down 14 after earnings
PremiumThe Fly
Closing Bell Movers: GitLab up 14%, Zscaler down 14 after earnings
7M ago
PD
ZS
Athira Pharma Discusses Clinical Trial and Financial Position
PremiumCompany AnnouncementsAthira Pharma Discusses Clinical Trial and Financial Position
7M ago
8K
ATHA
Athira Pharma trading resumes
Premium
The Fly
Athira Pharma trading resumes
7M ago
ATHA
Athira says clinical trial of fosgonimeton for AD primary endpoint not met
Premium
The Fly
Athira says clinical trial of fosgonimeton for AD primary endpoint not met
7M ago
ATHA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >